Do You Know Why the FDA Required Paxil to Change Its Labeling?
In December 2005, the Food and Drug Administration (FDA) alerted the health care professionals and patients that they should be aware of the pregnancy-related risks associated with Paxil (paroxetine) and similar antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Specifically, the FDA warned that Paxil posed birth defect risks to developing fetus, particularly when exposed during the first trimester.
Paxil is a dangerous drug, and as a result, thousands of families have suffered. Was your child born with a Paxil-related birth defect, such as persistent pulmonary hypertension (PPHN)? You should talk to the professionals at the law firm of Fears Nachawati. With years of experience and dedicated expertise, we know how to fight for you. Contact us today for your free consultation. Call us at 1.866.545.8364 or email email@example.com.